Northstrive Fund II has sent a letter to the Board of Directors of Bluejay Diagnostics Inc, recommending that they carefully evaluate a potential acquisition opportunity.
Show original
The acquisition target is a therapeutic asset for refractory chronic cough, which is now ready to enter Phase I clinical trials.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$70,546.76
+0.81%
Ethereum
ETH
$2,072.54
+1.96%
Tether USDt
USDT
$1
-0.00%
BNB
BNB
$651.83
+1.68%
XRP
XRP
$1.39
+0.59%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$87.25
+1.54%
TRON
TRX
$0.2901
+1.84%
Dogecoin
DOGE
$0.09406
-0.58%
Cardano
ADA
$0.2657
+1.13%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now